Vitamin C in chronic kidney disease and hemodialysis patients

Kidney and Blood Pressure Research

Volumn 26, Issue 2, 2003, Pages 100-106

  Deicher, Robert ^a   Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic kidney disease; Oxidative stress; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CARBONYL DERIVATIVE; DEHYDROASCORBIC ACID; IRON; LIPID; OXIDIZING AGENT; TRANSITION ELEMENT;

ANEMIA; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ASCORBYLATION; ATHEROSCLEROSIS; BLOOD PRESSURE; CHEMICAL REACTION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIALYSIS; DOSE CALCULATION; DRUG INDICATION; ENDOTHELIUM; HUMAN; IRON DEFICIENCY; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REDUCTION; REVIEW; UREMIA; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANEMIA, IRON-DEFICIENCY; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 0038654137     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070991     Document Type: Review

References (78)

1. Foley RN, Parfrey, PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(suppl 3):112-119.
2. Hasselwander O, Young IS: Oxidative stress in chronic renal failure. Free Radic Res 1998;29:1-11.
3. Galli F, Canestrari F, Bellomo G: Pathophysiology of the oxidative stress and its implication in uremia and dialysis. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 1-31.
4. Parthasarathy S, Khan-Merchant N, Penumetcha M, Khan BV, Santanam N: Did the anitoxidant trials fail to validate the oxidation hypothesis? Curr Atheroscler Rep 2001;3:392-398.
5. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-6381.
6. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N: Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: A prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 2001;357:657-663.
7. Loria CM, Klag MJ, Caulfield LE, Whelton PK: Vitamin C status and mortality in US adults. Am J Clin Nutr 2000;72:139-145.
8. Kurl S, Tuomainen TP, Laukkanen JA, Nyyssonen K, Lakka T, Sivenius J, Salonen JT: Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 2002;33:1568-1573.
9. Weber P, Bendich A, Schalch W: Vitamin C and health - A review of recent data relevant to human requirements. Int J Vitam Nutr Res 1996;66:19-30.
10. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL: Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001;103:1863-1868.
11. Lim PS, Wang NP, Lu TC, Wang TH, Hsu WM, Chan EC, Hung WR, Yang CC, Kuo IF, Wei YH: Evidence for alterations in circulating low-molecular weight antioxidants and increased lipid peroxidation in smokers on hemodialysis. Nephron 2001;88:127-133.
12. Lonn EM, Yusuf S: Is there a role for anitoxidant vitamins in the prevention of cardiovascular diseases: An update on epidemiological and clinical trials data. Can J Cardiol 1997;13:957-965.
13. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ: Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. Clin Sci 2002;103:339-344.
14. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:23-33.
15. Buettner GR: The pecking order of free radicals and antioxidants: Lipid peroxidation, α-tocopherol and ascorbate. Arch Biochem Biophys 1993;300:535-543.
16. Sies H, Stahl W, Sundquist AR: Antioxidant functions of vitamins. Vitamin E and C, β-carotene, and other caretenoids. Ann NY Acad Sci 1992;669:7-20.
17. Meister A: Mitochondrial changes associated with glutathione deficiency. Biochem Biophys Acta 1995;1271:35-42.
18. Cárcamo JM, Bórquez-Ojeda O, Golde DW: Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways. Blood 2002;99:3205-3212.
19. Kozlov AV, Ceccarelli D, Bini A, Meletti E, Gallesi D, Giovannini F, Masini A, Tomasi A: Low temperature EPR characterization of 'free' iron pools in liver in experimental iron overload: Effect of combined ethanol intoxication. J Magn Reson Anal 1997;3:141-148.
20. Lehnen-Beyel I, De Groot H, Rauen U: Enhancement of iron toxicity in L929 cells by D-glucose: Accelerated (re-)reduction. Biochem J 2002;368:517-526.
21. Courtois F, Delvin E, Ledoux M, Seidman E, Lavoie JC, Levy E: The antioxidant BHT normalizes some oxidative effects on iron + ascorbate on lipid metabolism in Caco-2 cells. J Nutr 2002;132:1289-1292.
22. Adhirai M, Selvam R: Effect of cyclosporin A on tissue lipid peroxidation and membrane bound phosphatases in hyperoxaluric rat and the protection by vitamin E pretreatment. Jpn J Med Sci Biol 1997;50:9-17.
23. Lee SH, Yoon YC, Jang YY, Song JH, Han ES, Lee CS: Effect of iron and ascorbate on cyclosporine-induced oxidative damage of kidney mitochondria and microsomes. Pharmacol Res 2001;43:161-171.
24. Rehman A, Collis CS, Yang M, Kelly M, Diplock AT, Halliwell B, Rice-Evans C: The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998;246:293-298.
25. Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-352.
26. Nagaraj RH, Shamsi FA, Huber B, Pischetsrieder M: Immunochemical detection of oxalate monoalkylamide, an ascorbate-derived Maillard reaction product in the human lens. FEBS Lett 1999;453:327-330.
27. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-1181.
28. Argirov OK, Lin B, Olesen P, Ortwerth BJ: Isolation and characterization of a new advanced glycation end-product of dehydroascorbic acid and lysine. Biochem Biophys Acta 2003;1620:235-244.
29. Stein G, Busch M, Muller A, Wendt T, Franke C, Niwa T, Franke S: Are advanced glycation end products cardiovascular risk factors in patients with CRF? Am J Kidney Dis 2003;41(suppl 2):52-56.
30. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000;87:840-844.
31. Aminbakhsh A, Mancini J: Chronic antioxidant use and changes in endothelial dysfunction: A review of clinical investigations. Can J Cardiol 1999;15:895-903.
32. Williams MJ, Sutherland WH, McCormick MP, de Jong SA, McDonald JR, Walker RJ: Vitamin C improves endothelial dysfunction in renal allograft recipients. Nephrol Dial Transplant 2001;16:1251-1255.
33. Feldstein A, Krier JD, Hershman Sarafov M, Lerman A, Best PJM, Wilson SH, Lerman LO: In vivo renal vascular and tubular function in experimental hypercholesterolemia. Hypertension 1999;34:859-864.
34. Stulak JM, Lerman A, Caccitolo JA, Wilson SH, Romero JC, Schaff HV, Rodrguez Porcel M, Lerman LO: Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia. Atherosclersosis 2001;154:195-201.
35. Stulak JM, Lerman A, Rodriguez Porcel M, Caccitolo JA, Romero JC, Schaff HV, Napoli C, Lerman LO: Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol 2001;12:1882-1891.
36. Ellis GR, Anderson RA, Lang D, Blackman DJ, Morris RH, Morris-Thurgood J, McDowell IF, Jackson SK, Lewis MJ Frenneaux MP: Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 2000;36:1474-1482.
37. McKechnie R, Rubenfire M, Mosca L: Antioxidant nutrient supplementation and brachial artery reactivity in patients with coronary artery disease. J Lab Clin Med 2002;139:133-139.
38. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P: Effects of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial. Lancet 2002;359:1108-1113.
39. D'Uscio L, Milstien S, Richardson D, Smith L, Katusic Z: Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 2003;92:88-95.
40. Hultquist M, Hegbrandt J, Nilsson-Thorell C, Lindholm T, Nilsson P, Lindén T, Hultquist-Bengtsson U: Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol 1997;47:37-46.
41. Wang S, Eide TC, Sogn EM, Berg KJ, Sund RB: Plasma ascorbic acid in patients undergoing chronic haemodialysis. Eur J Pharmacol 1999;55:527-532.
42. Nakayama H, Akiyama S, Inagaki M, Gotoh Y, Oguchi K: Dehydroascorbic acid and oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2001;16:574-579.
43. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, Delcourt C, Papoz L, Descomps B, Canaud B: Convective and diffuse losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002;17:422-427.
44. Burr ML, Sweetnam PM, Hurley RJ, Powell GH: Letter: Effects of age and intake on plasma-ascorbic acid levels. Lancet 1974;ii:163-164.
45. Pereira AM, Hamani N, Nogueira PC, Carvalhaes JT: Oral vitamin intake in children receiving long-term dialysis. J Ren Nutr 2000;10:24-29.
46. Singh RG, Gupta AK, Dubey SS, Usha, Sharma MR: Ascorbic acid status in uremics. Indian J Med Res 1992;96:266-269.
47. Rumsey SC, Levine M: Absorption, transport, and disposition of ascorbic acid in humans. J Nutr Biochem 1998;9:116-130.
48. Bohm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R: Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. In J Vitam Nutr Res 1997;67:262-266.
49. Du Plessis AS, Randall H, Escreet E, Höll M, Conradie M, Moosa MR, Labadarios D, Herselman MG: Nutritional status of renal transplant patients. S Afr Med J 2002;92:68-74.
50. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G: Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 2002;12:17-31.
51. Olmedilla B, Granado F, Southon S, Wright AJ, Blanco I, Gil-Martinez E, Berg H, Corridan B, Roussel AM, Chopra M, Thurnham DI: Serum concentrations of carotenoids and vitamins A, E and C in control subjects from five European countries. Br J Nutr 2001;85:227-238.
52. Fukunaga K, Takama K, Suzuki T: High-performance liquid chromatographic determination of plasma malondialdehyde level without a solvent extraction procedure. Anal Chem 1995;230:20-23.
53. Makoff R: Vitamin replacement therapy in renal failure patients. Miner Electrolyte Metab 1999;25:349-351.
54. Hörl WH: Is there a role for adjuvant therapy in patients being treated with epoetin? Nephrol Dial Transplant 1999;14(suppl 2):50-60.
55. Tarng DC, Wei YH, Huang TP, Kuo B, Yang WC: Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 1999;55:2477-2486.
56. 6, oxalic acid and vitamin C in chronic renal failure. Miner Electrolyte Metab 1999;25:352-356.
57. Hirsch IB, Atchley DH, Tsai E, Labbe RF, Chait A: Ascorbic acid clearance in diabetic nephropathy. J Diabetes Complications 1998;12:259-263.
58. Bakaev V, Efremov A, Tityaev I: Low levels of dehydroascorbic acid in uremic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis. Nephrol Dial Transplant 1999;14:1472-1474.
59. Clermont G, Lecour S, Cabanne J, Motte G, Guilland JC, Chevet D, Rochette L: Vitamin E-coated dialyzer reduces oxidative stress in haemodialysis patients. Free Radic Biol Med 2001;31:233-241.
60. Al-Ghamdi JM, Al-Jafari AA, Alhomida AS, Sobki SH, Al-Sulaiman MH, Al-Khader AA: Whole blood total, reduced and oxidized ascorbic acid levels in Saudi patients with chronic renal failure: influence of gender and chronic haemodialysis. Med Sci Res 1998;26:343-347.
61. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 1998;9:2349-2356.
62. Puskas F, Gergely P Jr, Banki K, Perl A: Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. Faseb J 2000;14:1352-1361.
63. Qutob S, Dixon SJ, Wilson JX: Insulin stimulates vitamin C recycling and ascorbate accumulation in osteoblastic cells. Endocrinology 1998;139:51-56.
64. Root-Bernstein R, Busik JV, Henry DN: Are diabetic neuropathy, retinopathy and nephropathy caused by hyperglycemic exclusion of dehydroascorbate uptake by glucose transporters? J Theor Biol 2002;216:345-359.
65. Goldenberg H, Schweinzer E: Transport of vitamin C in animal and human cells. J Bioenerg Biomembr 1994;26:359-367.
66. Will JC, Byers T: Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 1996;54:193-202.
67. Vander Jagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL: Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem 2001;34:265-270.
68. Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β and glomerular size in diabetes. J Am Soc Nephrol 1997;8:1405-1414.
69. Gaede P, Poulsen HE, Parving HH, Pedersen O: Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diab Med 2001;18:756-760.
70. Ness AR, Chee D, Elliott P: Vitamin C and blood pressure: an overview. J Hum Hypertens 1997;11:343-350.
71. Svetkey LP, Loria CM: Blood pressure effects of vitamin C: what's the key question? Hypertension 2002;40:789-791.
72. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GH, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, for the DASH-Collaborative Research Group: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-1124.
73. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure: European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 1999;14(suppl 5):1-50.
74. Gastaldello K, Vereerstraeten A, Nzame-Nze T, Vanherweghem JL, Tielemans C: Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant 1995;10(suppl 6):44-47.
75. Tarng DC, Huang TP: A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload. Nephrol Dial Transplant 1998;13:2867-2872.
76. Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M: Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs 2002;26:366-370.
77. Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F: Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. J Nephrol 2000;13:444-449.
78. Ziai F, Habicht A, Bieglmayer C, Deicher R, Hörl WH: Erythropoetin-Bedarf in Abhängig-keit vom Vitamin-C-Status bei Hämodialyse-patienten (abstract). Nieren- und Hochdruckkrankheiten 2002;31:437.